Selected article for: "lung injury and mouse model"
Author: DiPiazza, Anthony T.; Leist, Sarah R.; Abiona, Olubukola M.; Moliva, Juan I.; Werner, Anne; Minai, Mahnaz; Nagata, Bianca M.; Bock, Kevin W.; Phung, Emily; Schäfer, Alexandra; Dinnon, Kenneth H.; Chang, Lauren A.; Loomis, Rebecca J.; Boyoglu-Barnum, Seyhan; Alvarado, Gabriela S.; Sullivan, Nancy J.; Edwards, Darin K.; Morabito, Kaitlyn M.; Mascola, John R.; Carfi, Andrea; Corbett, Kizzmekia S.; Moore, Ian N.; Baric, Ralph S.; Graham, Barney S.; Ruckwardt, Tracy J.
Title: COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge
  • Cord-id: o1exzkwo
  • Document date: 2021_7_2
    • ID: o1exzkwo
    Snippet: Vaccine-associated enhanced respiratory disease (VAERD) was previously observed in some preclinical models of SARS and MERS coronavirus vaccines. We used the SARS-CoV-2 MA10 mouse model of acute lung injury to evaluate the immune response and potential for immunopathology in animals vaccinated with research-grade mRNA-1273. Whole-inactivated virus or heat-denatured spike protein subunit vaccines with alum designed to elicit low-potency antibodies and Th2-skewed CD4+ T cells resulted in reduced v
    Document: Vaccine-associated enhanced respiratory disease (VAERD) was previously observed in some preclinical models of SARS and MERS coronavirus vaccines. We used the SARS-CoV-2 MA10 mouse model of acute lung injury to evaluate the immune response and potential for immunopathology in animals vaccinated with research-grade mRNA-1273. Whole-inactivated virus or heat-denatured spike protein subunit vaccines with alum designed to elicit low-potency antibodies and Th2-skewed CD4+ T cells resulted in reduced viral titers and weight loss post-challenge, but more severe pathological changes in the lung compared to saline-immunized animals. In contrast, a protective dose of mRNA-1273 induced favorable humoral and cellular immune responses that protected from viral replication in the upper and lower respiratory tract upon challenge. A subprotective dose of mRNA-1273 reduced viral replication and limited histopathological manifestations compared to animals given saline. Overall, our findings demonstrate an immunological signature associated with antiviral protection without disease enhancement following vaccination with mRNA-1273.

    Search related documents:
    Co phrase search for related documents
    • additional information and low potency: 1
    • additional information and lung pathology: 1
    • low concentration and luciferase activity: 1
    • low concentration and luciferase reporter: 1
    • low expression and luciferase activity: 1
    • low expression and luciferase reporter: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • low expression and lung examine: 1
    • low expression and lung inflammation: 1, 2, 3, 4, 5
    • low expression and lung inflammatory response: 1, 2
    • low expression and lung pathology: 1
    • low expression and lung sample: 1
    • low immunogenicity and luciferase activity: 1
    • low immunogenicity and lung cytokine: 1
    • low immunogenicity and lung inflammation: 1
    • low induce and luciferase activity: 1